Movano Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Movano Health sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed upper quartile by trial count

Movano Health: 3 sponsored US clinical trials, 1 recruiting.

Movano Health sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Hypoxia, with 1 trials.

Upper-quartile sponsor footprint

Movano Health sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia

NCT06459206
COMPLETED

Accuracy of Evie Ring Pulse Oximeter in Profound Hypoxia

NCT06101654
COMPLETED

Accuracy of Pulse Oximeters in Profound Hypoxia

NCT05920278

Therapeutic Areas

Hypoxia 1

What is open in the Movano Health pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hypoxia (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Movano Health: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Movano Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Movano Health10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Movano Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Movano Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Movano Health page

3 registered trials is a research-attention snapshot, not an endorsement of Movano Health or any single study.

  • 1 of Movano Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypoxia is the condition Movano Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoxia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Movano Health pipeline card: 3 registered trials from official public datasets.Report a data error.